Purchase Order HT942524P0103
Award Date
9/6/24
Potential Completion Date
3/5/26
Potential Value
$180K
Federal Agency
Defense Health Agency
Awardee
Genovac Antibody Discovery LLC
Ultimate Awardee
Not listed
PSC Category
B537 - Special Studies/Analysis- Medical/Health
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20910, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Health Agency awarded a $84,720.53 firm fixed price purchase order to Genovac Antibody Discovery LLC, a small disadvantaged business, for the generation of monoclonal antibodies targeting ferret immunoglobulin M and immunoglobulin G. This requirement was solicited as a 100% small business set-aside. The contract has an ultimate completion date of December 29, 2023 and was awarded on May 1, 2023. The contract was issued under a federal contract opportunity posted on April 7, 2023 with...
This is a $1,264,126.01 firm-fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Green Mountain Antibodies Inc. for research and development services related to developing monoclonal antibodies against the ESKAPEE pathogens. The contract has a base period of performance from September 30, 2020 to September 29, 2021, with four one-year option periods extending the potential completion date to September 29, 2025. This contract was awarded on a sole-source basis to a small...
This is a $3,010,545.01 firm fixed-price definitive contract awarded by the Defense Health Agency (DHA) to Integrum Scientific LLC, a self-certified small disadvantaged business, for blood collection and database creation services. The contract supports the development of monoclonal antibody therapeutics and evaluation of the immune responses in survivors of Marburg Virus disease (MVD) outbreaks in Uganda and Venezuelan Equine Encephalitis (VEE) outbreaks in Panama. The contractor will...
This is a $110,500.00 firm fixed-price delivery order contract awarded by the Defense Health Agency, a defense agency, to Mapp Biopharmaceutical, Inc., a biotechnology company based in San Diego, California. The contract is for the supply of antibodies and antigens, and has an ultimate completion date of September 5, 2025. The contract does not have a set-aside designation. Mapp Biopharmaceutical has established itself as a key partner in advancing medical research and preparedness for...
<p>This is a firm fixed-price purchase order contract awarded to Antibody Solutions, a small business subchapter S corporation, by the Food and Drug Administration (FDA), a civilian agency. The contract is for the production of monoclonal antibodies clones, with a ceiling value of $272,402.00 and a performance period ending on July 31, 2029. The contract is set aside for small businesses.</p>
This is a $17,484.25 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of dengue antibodies and related services to support NIAID's biomedical research and public health initiatives. Genscript, which is not a small business, has experience providing...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services (HHS), for a CUSTOM ANTIBODY PROJECT. The contract was awarded to Aves Laboratories, a self-certified small disadvantaged, woman-owned, Asian-Pacific American-owned business, on March 22, 2016 with a completion date of April 21, 2016 and a ceiling value of $33,917.00. The contract does not have a set-aside...
The National Institutes of Health National Institute of Allergy and Infectious Diseases (NIH NIAID) awarded a $59,541 firm fixed price purchase order to Genscript USA Inc. to provide customized antibody synthesis, expression, purification, and plasmid preparations in support of the Laboratory of Malaria Immunology and Vaccinology's (LMIV) malaria vaccine research. Per the original solicitation, LMIV requires custom monoclonal antibodies that can label and sort immune cell subsets in its colony...
The U.S. Department of Health and Human Services (HHS), through the National Institute of Allergy and Infectious Diseases (NIAID), awarded a $5,286.50 firm-fixed-price purchase order to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for custom antibody generation services. The award, with a completion date of December 18, 2013, is not associated with a set-aside designation. Precision Antibody is a for-profit manufacturer of goods specializing in custom antibody...
This is a $97,722.00 firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the provision of monoclonal antibodies and plasmids services to support NIAID's research initiatives, with a completion date of September 19, 2025. This contract is not designated as a set-aside....